Autopsy report · NCT00637780
Study To Determine The Pharmacokinetics Of Sulfasalazine In Children With Juvenile Idiopathic Arthritis
Cause of deathFunding or business
“Study terminated on 13 April 2016 for business reasons. No safety and/or efficacy concerns contributed to the termination of the study”
Life of this trial
- Registered 2 years 3 months before it started.
- Ran for about 3 years 7 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 3 years 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Arthritis, Juvenile Rheumatoid
- Interventions
- Sulfasalazine
- Participants
- 2
- Sites
- 2
- Countries
- Mexico, United States
Trials that died the same way
- Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting
“The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated for reasons of either safety or efficacy.” - An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
“The termination was due to business reasons. No safety or efficacy concerns contributed to the termination of the study” - A Study to Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration
“The study terminated for safety reasons” - An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida
“The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not terminated due to any safety issues or concerns.” - A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
“The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.